Performance of some multiple testing procedures to compare three doses of a test drug and placebo

Pharmaceutical Statistics

Volumn 4, Issue 1, 2005, Pages 25-35

  Kong, Lan ^a   Koch, Gary ^b   Liu, Thomas ^c   Wang, Huei ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b IL   (United States)

^c AMGEN INC   (United States)

Author keywords

Closed testing procedure; Familywise Type I error; Multiple comparison; Power

Indexed keywords

ANTIHYPERTENSIVE AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LORAZEPAM; OLANZAPINE; PLACEBO;

ANALYSIS OF VARIANCE; ANALYTICAL ERROR; ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG MEGADOSE; DRUG SYNTHESIS; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HYPERTENSION; HYPOTHESIS; INTERMETHOD COMPARISON; LINEAR SYSTEM; LOW DRUG DOSE; MULTIPLE DRUG DOSE; NORMAL DISTRIBUTION; RESTLESSNESS; RHEUMATOID ARTHRITIS; SIMULATION; SUPINE POSITION;

EID: 15844389520     PISSN: 15391604     EISSN: None     Source Type: Journal    
DOI: 10.1002/pst.148     Document Type: Article

References (18)

1. Koch GG, Gansky SA. Statistical considerations for multiplicity in confirmatory protocols. Drug Information Journal 1996; 30:523-534.
2. Ruberg SJ. Dose response studies. I. Some design considerations. Journal of Biopharmaceutical Statistics 1995; 5 1):1-14.
3. Tangen CM, Koch GG. Non-parametric analysis of covariance for confirmatory randomized clinical trials to evaluate dose-response relationships. Statistics in Medicine 2001; 20(17):2585-2607.
4. Hochberg Y, Tamhane AC. Multiple comparison procedures. Wiley: New York, 1987.
5. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75:800-802.
6. Hsu JC. Multiple comparisons: theory and methods. Chapman & Hall: London, 1996.
7. Hommel G. A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 1988; 75:383-386.
8. Dunnett CW, Tamhane AC. A step-up multiple test procedure. Journal of the American Statistical Association 1992; 87 162-170.
9. Tamhane AC, Hochberg Y, Dunnett CW. Multiple test procedures for dose finding. Biometrics 1996; 52:21-37.
10. Westfall PH, Tobias RD, Rom D, Wolfinger RD, Hochberg Y. Multiple comparisons and multiple tests using SAS®. SAS Institute Inc.: Cary, NC, 1999.
11. Williams DA. A test for difference between treatment means when several dose levels are compared with a zero dose control. Biometrics 1971; 27: 103-117.
12. Williams DA. The comparison of several dose levels with a zero dose control. Biometrics 1972; 28: 519-531.
13. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 1976; 63:655-660.
14. Sarkar S, Chang CK. The Simes method for multiple hypothesis testing with positively dependent test statistics. Journal of the American Statistical Association 1997; 92:1601-1608.
15. Phillips JA, Cairns V, Koch GG. The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology. Journal of Biopharmaceutical Statistics 1992; 2 1):49-67.
16. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis & Rheumatism 1998; 41(12):2196-2204.
17. Meehan KM, Wang H, David SR, Nisivoccia JR, Jones B, Beasley CM, Feldman PD, Mintzer JE, Beckett LM, Breier A. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 2002; 26(4):494-504.
18. Dmitrienko A, Offen WW, Westfall PH. Gate-keeping strategies for clinical trials that do not require all primary effects to be significant. Statistics in Medicine 2003; 22(15):2387-2400.